Stefano Panni

1.5k total citations
23 papers, 182 citations indexed

About

Stefano Panni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stefano Panni has authored 23 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Stefano Panni's work include Cancer Immunotherapy and Biomarkers (11 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Stefano Panni is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Stefano Panni collaborates with scholars based in Italy, United Kingdom and United States. Stefano Panni's co-authors include Margherita Ratti, Matteo Brighenti, Gianluca Tomasello, Michele Ghidini, Fausto Petrelli, Sandro Barni, Alfredo Berruti, Mary Cabiddu, Karen Borgonovo and Giulia Grizzi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Stefano Panni

22 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefano Panni Italy 7 141 61 32 27 19 23 182
Mikako Ishijima Japan 7 122 0.9× 107 1.8× 27 0.8× 20 0.7× 16 0.8× 15 176
Haiyi Deng China 10 172 1.2× 151 2.5× 26 0.8× 24 0.9× 22 1.2× 33 246
Vasiliki Michalarea United Kingdom 7 104 0.7× 54 0.9× 31 1.0× 17 0.6× 7 0.4× 17 162
Diana Isabel Rosero Spain 7 101 0.7× 57 0.9× 30 0.9× 42 1.6× 17 0.9× 11 205
Masayuki Shirasawa Japan 10 167 1.2× 108 1.8× 19 0.6× 24 0.9× 16 0.8× 25 213
Takehiro Tozuka Japan 10 198 1.4× 156 2.6× 18 0.6× 23 0.9× 17 0.9× 33 249
Michal Kubiak United States 5 114 0.8× 47 0.8× 22 0.7× 43 1.6× 12 0.6× 10 197
Patrick O’Donnell United States 5 77 0.5× 49 0.8× 41 1.3× 17 0.6× 7 0.4× 14 122
James Haberberger United States 9 119 0.8× 103 1.7× 26 0.8× 24 0.9× 13 0.7× 18 204
Denise Lau United States 8 141 1.0× 63 1.0× 46 1.4× 39 1.4× 9 0.5× 19 191

Countries citing papers authored by Stefano Panni

Since Specialization
Citations

This map shows the geographic impact of Stefano Panni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Panni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Panni more than expected).

Fields of papers citing papers by Stefano Panni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Panni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Panni. The network helps show where Stefano Panni may publish in the future.

Co-authorship network of co-authors of Stefano Panni

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Panni. A scholar is included among the top collaborators of Stefano Panni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Panni. Stefano Panni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedman, Claire F., Anishka D'souza, Diana Bello Roufai, et al.. (2024). Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial. Gynecologic Oncology. 181. 162–169. 15 indexed citations
2.
Schettini, Francesco, Estela Pineda, Andrea Rocca, et al.. (2024). Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses. The Oncologist. 30(7). 2 indexed citations
3.
Sobhani, Navid, Andrea Rocca, Alberto D’Angelo, et al.. (2023). Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report. Biomedicines. 11(2). 311–311. 9 indexed citations
4.
5.
Sternberg, Cora N., Yohann Loriot, Rosa Tambaro, et al.. (2020). Atezolizumab (atezo) therapy for upper tract (UT) urothelial carcinoma (UC): Subgroup analysis of the single-arm international SAUL study in pretreated locally advanced/metastatic urinary tract carcinoma.. Journal of Clinical Oncology. 38(6_suppl). 488–488. 2 indexed citations
6.
Ravanelli, Marco, Giorgio Maria Agazzi, Gianluca Milanese, et al.. (2019). Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study. European Journal of Radiology. 118. 251–256. 12 indexed citations
7.
Petrelli, Fausto, Giulia Grizzi, Michele Ghidini, et al.. (2019). Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Journal of Immunotherapy. 43(1). 1–7. 86 indexed citations
8.
Masini, Cristina, Cinzia Iotti, Patrizia Ciammella, et al.. (2018). NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 36(15_suppl). TPS4602–TPS4602. 4 indexed citations
9.
Cortesi, Enrico, Federico Cappuzzo, Luca Galli, et al.. (2017). Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP). Annals of Oncology. 28. v316–v316. 4 indexed citations
10.
Brighenti, Matteo, Fausto Petrelli, Sandro Barni, et al.. (2017). Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?. European Journal of Cancer. 79. 149–151. 9 indexed citations
11.
Passalacqua, Rodolfo, Silvia Lazzarelli, Maddalena Donini, et al.. (2017). Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014). BMC Cancer. 17(1). 493–493. 4 indexed citations
12.
Bersanelli, Melissa, Elisabetta Gambale, Alessio Cortellini, et al.. (2017). Influenza vaccine indication during anticancer therapy with immune-checkpoint inhibitors: A transversal challenge for patient’s counselling – preliminary analysis of the INVIDIa study. Annals of Oncology. 28. xi17–xi17. 3 indexed citations
13.
14.
Panni, Stefano, Silvia Lazzarelli, Matteo Brighenti, et al.. (2017). High baseline lymphocyte count is a predictive biomarker of prolonged time to progression in patients with advanced solid tumors receiving checkpoint inhibitors.. Journal of Clinical Oncology. 35(15_suppl). e14532–e14532. 3 indexed citations
15.
Ghidini, Michele, Jens C. Hahne, Francesco Trevisani, et al.. (2016). New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. Therapeutics and Clinical Risk Management. Volume 12. 1009–1015. 9 indexed citations
16.
Passalacqua, Rodolfo, Silvia Lazzarelli, Rodolfo Montironi, et al.. (2016). Vinflunine (VFL) in patients (pts) with metastatic transitional cell carcinoma of the urothelial tract (mTCCU): Clinical outcome and prognostic factors in a nationwide, real-life setting (MOVIE trial).. Journal of Clinical Oncology. 34(15_suppl). e16031–e16031. 4 indexed citations
17.
Buti, Sebastiano, Paola Bordi, Marcello Tiseo, et al.. (2015). Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. Lung Cancer. 88(3). 319–324. 6 indexed citations
18.
19.
Buti, Sebastiano, Paola Bordi, Marcello Tiseo, et al.. (2012). Erythrocyte Mean Corpuscular Volume Change During Pemetrexed Treatment in Advanced Non Small Cell Lung Cancer Patients. Annals of Oncology. 23. ix442–ix442. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikako Ishijima Breakdown of academic impact, for papers by Haiyi Deng Breakdown of academic impact, for papers by Vasiliki Michalarea Breakdown of academic impact, for papers by Diana Isabel Rosero Breakdown of academic impact, for papers by Masayuki Shirasawa Breakdown of academic impact, for papers by Takehiro Tozuka Breakdown of academic impact, for papers by Michal Kubiak Breakdown of academic impact, for papers by Patrick O’Donnell Breakdown of academic impact, for papers by James Haberberger Breakdown of academic impact, for papers by Denise Lau
Rankless by CCL
2026